Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
133%(4 trials)
Terminated
1(25%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completed

Characteristics of Pts Initiating Spiriva Respimat in Asthma

NCT03692676
terminated

Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drug

NCT05362487
completed

Specific Use-Result of Spiriva Respimat® in Asthmatics

NCT03188120
completed

Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy

NCT02173769

Clinical Trials (4)

Showing 4 of 4 trials
NCT03692676

Characteristics of Pts Initiating Spiriva Respimat in Asthma

Completed
NCT05362487

Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drug

Terminated
NCT03188120

Specific Use-Result of Spiriva Respimat® in Asthmatics

Completed
NCT02173769

Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4